Yanling Shao
Papers
1
Total Citations
14
H-Index
1
About
Dr. Yanling Shao is a leading hepatobiliary surgeon whose research focuses on advancing minimally invasive surgical techniques for liver cancer, particularly hepatocellular carcinoma (HCC). Her major contribution lies in rigorously comparing robotic and laparoscopic liver resection to determine their relative efficacy and safety. Her most-cited 2024 study, a propensity score-matched retrospective cohort analysis, provides critical evidence on long-term outcomes for HCC patients undergoing these procedures—an area where data was previously scarce. With 14 citations already, this work has quickly become a reference point for surgeons weighing the benefits of robotic versus laparoscopic approaches. Dr. Shao’s research directly addresses the pressing need for high-quality comparative data in surgical oncology, helping to guide clinical decision-making and improve patient outcomes. Her meticulous methodology and focus on real-world evidence mark her as an emerging authority in the field, shaping the future of liver cancer surgery through innovation and evidence-based practice.
Research Focus
Key Achievements
Top Papers
- 1